Zepp Health Corporation
ZEPP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,333 | $2,498 | $4,216 | $6,169 |
| % Growth | -46.6% | -40.8% | -31.7% | – |
| Cost of Goods Sold | $821 | $1,844 | $3,398 | $4,880 |
| Gross Profit | $513 | $654 | $817 | $1,289 |
| % Margin | 38.5% | 26.2% | 19.4% | 20.9% |
| R&D Expenses | $337 | $365 | $526 | $508 |
| G&A Expenses | $181 | $0 | $0 | $0 |
| SG&A Expenses | $521 | $505 | $708 | $688 |
| Sales & Mktg Exp. | $339 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $858 | $869 | $1,235 | $1,196 |
| Operating Income | -$345 | -$216 | -$417 | $93 |
| % Margin | -25.9% | -8.6% | -9.9% | 1.5% |
| Other Income/Exp. Net | -$109 | -$22 | $56 | $53 |
| Pre-Tax Income | -$454 | -$237 | -$361 | $146 |
| Tax Expense | $100 | -$17 | -$67 | $11 |
| Net Income | -$554 | -$220 | -$293 | $136 |
| % Margin | -41.6% | -8.8% | -7% | 2.2% |
| EPS | -136.64 | -7.84 | -10.84 | 5.52 |
| % Growth | -1,642.9% | 27.7% | -296.4% | – |
| EPS Diluted | -136.64 | -7.84 | -10.84 | 5.24 |
| Weighted Avg Shares Out | 4 | 4 | 4 | 4 |
| Weighted Avg Shares Out Dil | 4 | 4 | 4 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $27 | $22 | $13 | $16 |
| Interest Expense | $41 | $48 | $58 | $44 |
| Depreciation & Amortization | $37 | $54 | $60 | $51 |
| EBITDA | -$346 | -$143 | -$261 | $201 |
| % Margin | -25.9% | -5.7% | -6.2% | 3.3% |